- 期刊
嚴重特殊傳染性肺炎COVID-19後遺症中醫治療病例報告
Traditional Chinese Medicine for Post-COVID Condition: A Case Report
摘要
COVID-19確診後常有許多後遺症，在此分享一個服西藥卻遲遲不癒的咳嗽病例以及其治療經過。64歲女性，2022年9月3日確診COVID-19，服鎮咳西藥治療後仍持續劇烈咳嗽，甚至出現胸痛，故於2022年9月19日開始尋求中醫治療，經中醫濃縮中藥治療1週後，咳嗽即明顯改善，且已無胸痛，再經數週的調理後，這位患者難纏的咳嗽已近痊癒。
並列摘要
Most of COVID-19 survivors may develop sequelae. In this study, we present a patient with refractory cough after being infeceted with SARS-CoV-2. This 64-year-old woman complained severe cough since she was diagnosed with COVID-19 on September 3, 2022. She took antitussive agents, but found that cough did not improve. She even developed symptoms of chest pain in the following days. Therefore, sheseekedadvicefrom traditional Chinese medicinesince September 19, 2022. Symptoms improved significantly within 1 week, and almost cured in 1.5 month.
參考文獻
Qing Han, Bang Zheng, Luke Daines, and Aziz Sheikh.Long-Term Sequelae of COVID-19 : A Systematic Review and Meta-Analysis of One-Year Follow-Up Studies on Post-COVID Symptoms. Pathogens. 2022 Feb ; 11(2): 269.doi : 10.3390/pathogens11020269.
Eleni Gavriilaki, Styliani Kokoris. COVID-19 sequelae : can long-term effects be predicted?. The Lancet, 2022 August ; 22(12): 1651-1652. doi : 10.1016/S1473-3099(22)00529-1
Woo-Jung Song, Christopher K M Hui, James H Hull, Surinder S Birring, Lorcan McGarvey, Stuart B Mazzone, Kian Fan Chung. Confronting COVID-19-associated cough and the post-COVID syndrome : role of viral neurotropism, neuroinflammation, and neuroimmune responses. The Lancet : Respiratory medicine, 2021 May ; 9(5): 533-544. doi: 10.1016/S2213-2600(21)00125-9
RasoolSoltani, Sara Nasirharandi, FarzinKhorvash, Maryam Nasirian, Kian Dolatshahi, Atousa Hakamifard. The effectiveness of gabapentin and gabapentin/montelukast combination compared with dextromethorphan in the improvement of COVID-19 related cough : A randomized, controlled clinical trial. The clinical respiratory journal 2022 Sep; 16(9): 604-610. doi: 10.1111/crj.13529
楊維傑, 黃帝內經素問譯解, 脈要精微論, 志遠書局, 2001 年, p. 144